Zobrazeno 1 - 10 of 42 pro vyhledávání: '"William T. McGivney"'
1
Akademický článek
The Value of Cancer Immunotherapy Summit at the 2016 Society for Immunotherapy of Cancer 31st Anniversary Annual Meeting
Autor: Howard L. Kaufman, Michael B. Atkins, Adam P. Dicker, Heather S. Jim, Louis P. Garrison, Roy S. Herbst, William T. McGivney, Steven Silverstein, Jon M. Wigginton, Peter P. Yu
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-10 (2017)
Abstract As healthcare costs continue to rise, there has been great interest in understanding and defining the value of current therapeutic strategies for the treatment of cancer. Cancer immunotherapy has emerged as a clinically beneficial alternativ
Externí odkaz: https://doaj.org/article/57af0b0ce256407499283c283c70abc3
Zobrazit plný text záznamu
2
Genomic testing in oncology to improve clinical outcomes while optimizing utilization: the evolution of diagnostic testing
Autor: David C, Collymore, Shaunna L, Kobilis, Thomas G, Lundquist, William T, McGivney, Edmund J, Pezalla, Wendy, Poage
Publikováno v: The American journal of managed care. 22
Cancer care is costly, particularly when chemotherapy and its supportive costs are considered. Yet, chemotherapy is not the right course for every patient. Patients with cancer need appropriate treatment that will give them the best possible outcome.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::097b29da715512d352bf68766bb05f8f
https://pubmed.ncbi.nlm.nih.gov/26978033
Zobrazit plný text záznamu
3
NCCN: your best resource in the fight against cancer
Autor: William T. McGivney
Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN. 13(2)
An oncologist came up to me not that many years ago and said, “We thank NCCN; NCCN is our last, best hope.” Those words still ring true. The policies and processes in the cancer care delivery system increasingly attempt to limit the autonomy and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4f20768c20557dc2f8d6d0d8793a831
https://pubmed.ncbi.nlm.nih.gov/25691603
Zobrazit plný text záznamu
6
Forecasting financial impact of alternative payment models to cancer drug manufacturers
Autor: Jennifer M. Hinkel, William T McGivney, Daniel B. Sexton
Publikováno v: Journal of Clinical Oncology. 35:6549-6549
6549 Background: Payers are moving from fee-for-service (FFS) reimbursement models towards value-based Alternative Payment Models (APMs). In Medicare, this trend has emerged via MACRA legislation and the Oncology Care Model (OCM). Reimbursement chang
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ace17c0e3d6ee7fc5c40591dbefb1ccd
https://doi.org/10.1200/jco.2017.35.15_suppl.6549
Zobrazit plný text záznamu
7
The National Comprehensive Cancer Network
Autor: William T. McGivney
Publikováno v: Cancer. 82:2057-2060
The National Comprehensive Cancer Network (NCCN) has developed an extensive set of practice guidelines that cover approximately 90% of all cancer patients. These guidelines are steadily becoming the standard for clinical and coverage policy. The guid
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8747263134310be2a8df6b0c113a118f
https://doi.org/10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje